Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal

Not Applicable

• Conditions: Vaccine Acceptance

• Registration Number: NCT05378438
• Lead Sponsor: Nepal Health Research Council

Brief Summary

This study is designed to assess the impact of the first introduction of microscope-based health education on people's attitude and practice towards disease prevention in Nepal, measured by vaccine acceptance rate. Such health education has an important role to play in communities where vaccine acceptance is low.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-05-12
• Study First Submitted QC: 2022-05-12
• Study First Posted: 2022-05-18
• Status Verified: 2022-07
• Last Update Submitted: 2022-07-05
• Last Update Posted: 2022-07-06
• Study Start: 2022-07-15
• Primary Completion: 2022-09-30
• Study Completion: 2023-04-17

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1252

Inclusion Criteria

• People aged 18 years or older who are resident of the study target area
• People who stayed at least for 6 months on the area of study
• People who agrees with the procedure of study and follow ups visits
• People who provide consent for their participation will be recruited in the study.

Exclusion Criteria

• People under 18 years of age will not be enrolled into study due to their limitation of understanding and implementation of the content of workshop given as intervention.
• People who do not wish to participate in the trial
• Those with currently ongoing court hearing and deprive of freedom will not be enrolled for the study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Differential vaccine acceptance rates between intervention and control group	Within 3 months of intervention	Data will be collected for baseline as well as post intervention after 3 months of workshop. For both the intervention and control group, number of vaccinated among the participants for provided COVID-19 vaccine and Typhoid vaccine will be made. Comparative analysis will be made in both the study groups before and after the intervention program.

Trial Locations

Locations (1)

Nepal Health Research Council; 🇳🇵 Kathmandu, Bagmati, Nepal